| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.0096 | 1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.006 | 1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |